Marbles Health - Comprehensive Analysis Report

Summary

Marbles Health, founded in 2020 by Ramya Yellapragada and Lakshay Sahni, is a neurotech startup headquartered in Gurgaon, India. The company is dedicated to reimagining brain care and aims to make brain strength a core part of modern healthcare. Marbles Health focuses on developing accessible and effective medical devices that utilize neuromodulation to treat psychiatric and neurological disorders. Its approach integrates cutting-edge technology, psychology, neurosciences, and artificial intelligence with breath work and movement therapy to provide comprehensive e-services for brain health. The company's mission is to address the gap in safe, effective, and timely treatment for neurological and neuropsychiatric conditions, establishing itself as a leader in brain health solutions.

1. Strategic Focus & Objectives

Core Objectives

The primary business objectives of Marbles Health revolve around addressing the significant unmet need for safe, effective, and timely treatment for neurological and neuropsychiatric conditions.

Market Leadership: Establish Marbles Health as a leading provider of brain health solutions, specifically targeting both psychiatry and neurology segments.

Scaling Flagship Device: Scale the adoption and use of its flagship device, EASE, across India, making advanced neuromodulation technology widely available.

Application Expansion: Broaden the application of its technology within neurology to treat a wider range of conditions.

Affordable Access: Develop more affordable direct-to-consumer (D2C) versions of its existing technology to increase accessibility for individual users.

Revenue Growth: Achieve INR 100 Cr in annual recurring revenue (ARR) within the next three years, demonstrating strong market penetration and financial growth.

Global Expansion: Explore and pursue opportunities for international collaboration and expansion, positioning the company as a global player in neurotech.

Specialization Areas

Marbles Health specializes in the convergence of advanced technology, psychology, neurosciences, and artificial intelligence to develop e-medicine solutions for brain healthcare.

Neuromodulation Devices: Development and deployment of non-invasive brain stimulation devices for therapeutic intervention.

Integrated Therapy: Combining neuromodulation with brain monitoring (EEG), cognitive-emotional training, breath work, and movement therapy.

Personalized Protocols: Leveraging technology to enable personalized treatment protocols tailored to individual patient needs.

Affordable Innovation: Focusing on making sophisticated neurotechnology significantly more affordable and accessible than existing market options.

Target Markets

Marbles Health targets distinct market segments through its strategic models:

Business-to-Business (B2B): Psychiatrists, neurologists, and hospitals purchase the EASE device for clinical use, integrating it into their treatment offerings. This model facilitates widespread adoption through established healthcare providers.

Business-to-Business-to-Consumer (B2B2C): Doctors prescribe at-home treatment sessions, which are then delivered by the Marbles Health team to patients within their homes. This extends the reach of treatment beyond clinic walls.

Direct-to-Consumer (D2C - Upcoming): Future plans include a more affordable consumer version of EASE, targeting individuals seeking at-home brain health solutions directly. This will broaden market access significantly.

Specific Conditions: The target conditions include depression, anxiety, ADHD, OCD, addiction disorders, phobias, aphasia, mild cognitive impairment, and post-stroke mobility loss.

Specialized Digital Support: Development of a Marbles Application initially targeting oncology patients for mental resilience and support.

2. Financial Overview

Funding History

Marbles Health has raised a total funding of $289,000 across one seed round which closed on September 1, 2022.

Total Funds Raised: $289,000 in seed funding.

Key Investors: Capital 2B, Whiteboard Capital, and Novartis, alongside government grants and direct support from the Department of Biotechnology, Government of India, and AIIMS New Delhi.

Fund Utilization and Growth Impact: The funding supports the company's research and development efforts, scaling of the EASE platform across India, and development of new product offerings. As of September 2022, the company's founder net worth was INR 10.9 Cr, with founders Ramya Yellapragada and Lakshay Sahni holding 72.78% of shares, fund investments at 17.3%, and an ESOP (Employee Stock Option Plan) pool at 9.94%. Revenue is generated from device sales and treatment sessions. The company is preparing to raise approximately $5 million (₹45 crore) to further enhance its EASE platform and introduce new solutions.

3. Product Pipeline

Key Products/Services

Product Name: EASE (Executive Functioning and Affective Salience through Stimulation and EEG)

Description: India's first portable, non-invasive brain stimulation device designed for therapeutic intervention in psychiatric and neurological disorders. It combines neuromodulation, brain monitoring (EEG), and cognitive-emotional training.

Development Stage: Clinically approved and actively in use across India at 37 clinics, including Uttar Pradesh University of Medical Sciences (UPUMS), CIP Ranchi, KMC Manipal, and Mind and Brain Hospital. Over 1,200 doctors are utilizing the device.

Target Market/Condition: Treats depression, anxiety, ADHD, OCD, addiction disorders, phobias, aphasia, mild cognitive impairment, and post-stroke mobility loss.

Expected Timeline: Currently available and scaling.

Key Features and Benefits: Non-invasive, portable, provides personalized neuromodulation, simultaneously monitors brain activity, shows 63.8% reduction in depression scores within 10 days, and has facilitated over 3,000 patient sessions since its pilot launch. Priced at approximately ₹2.5 lakh for clinics, making it significantly more affordable than international alternatives.

Product Name: Direct-to-Consumer (D2C) Version of EASE

Description: A more affordable, user-friendly version of the EASE device for direct purchase and at-home use.

Development Stage: Actively under development and in the R&D phase.

Target Market/Condition: Individuals seeking accessible at-home brain health solutions for various conditions currently addressed by EASE.

Expected Timeline: Expected to launch in the coming years after R&D.

Key Features and Benefits: Anticipated to be priced around ₹25,000, significantly increasing accessibility and affordability for a broader consumer base.

Product Name: Motor Stimulation Device

Description: A specialized device for stimulating motor functions.

Development Stage: Undergoing R&D and early trials.

Target Market/Condition: Patients needing to regain movement after strokes or injuries.

Expected Timeline: Expected to launch in the coming years after R&D.

Key Features and Benefits: Early trials show promising results, with recovery evident within 20 days. Aims to significantly improve rehabilitation outcomes.

Product Name: Marbles Application (initially focused on Oncology)

Description: A digital support application providing mental health resources and tools.

Development Stage: Under development.

Target Market/Condition: Initially focused on supporting cancer patients to manage distress, build emotional resilience, reduce recurrence risks, and enhance overall quality of life during pre- and post-treatment phases. Future plans include supporting pre- and post-pregnancy brain health.

Expected Timeline: Launch expected after further development.

Key Features and Benefits: Aims to provide specialized and accessible digital mental health support for specific patient populations.

4. Technology & Innovation

Technology Stack

Marbles Health leverages a sophisticated technology stack rooted in advanced neuroscience, psychology, and artificial intelligence to deliver its e-medicine solutions.

Core Platforms and Technologies: The EASE device combines transcranial Electrical Stimulation (tES), Electroencephalography (EEG), and cognitive-emotional training. The tES, a form of transcranial direct current stimulation (tDCS), delivers mild electrical signals.

Proprietary Developments: The EASE device is a proprietary system where the upper part administers tES neuromodulation, while the lower part consistently monitors brain activity through EEG. This integrated approach allows for both therapeutic intervention and diagnostic insights. The connected dashboard enables healthcare professionals to set and manage personalized treatment protocols.

Scientific Methodologies: The non-invasive technology utilizes transcranial electrical stimulation (tES) in conjunction with real-time EEG monitoring and cognitive training. AI is being integrated into the technology roadmap to further personalize neuromodulation protocols, interpret complex EEG signals, and monitor cognitive and emotional outcomes, working towards predictive models for individualized brain healthcare.

Technical Capabilities: The company has expertise in developing portable medical devices, creating intuitive physician dashboards, and managing data from brain activity for personalized interventions. Validation studies, including one at AIIMS Delhi with 25 patients, have been conducted.

Patents and Intellectual Property

EASE has received official approval from the Central Drugs Standard Control Organisation (CDSCO), signifying its status as India's first medically licensed portable neuromodulation system.

The device also holds over 8 ISO/IEC approvals, attesting to its compliance with international quality and safety standards.

5. Leadership & Management

Executive Team

Ramya Yellapragada:

Position: Co-founder and CEO

Professional Background: Holds a computer science degree from Indraprastha Institute of Information Technology, Delhi, with a specialized focus on computational biology and neuroscience.

Notable Achievements: Co-founded Marbles Health, leading its strategic direction and product development.

Key Contributions to the Company: Drives the company's vision for reimagining brain care and making advanced neurotech accessible.

Lakshay Sahni:

Position: Co-founder and CTO

Professional Background: An electronics engineer from Delhi Technological University, with a background in neuroscience-inspired artificial intelligence and spiking neural networks.

Notable Achievements: Co-founded Marbles Health, overseeing its technological innovation and product architecture.

Key Contributions to the Company: Responsible for the technical development and proprietary platforms, including the EASE device.

LinkedIn Profile: [https://www.linkedin.com/in/lakshaysahni](https://www.linkedin.com/in/lakshaysahni)

6. Talent and Growth Indicators

Hiring Trends and Workforce

Marbles Health currently employs approximately 20 people.

Key Roles Being Recruited: A significant majority of the workforce is dedicated to R&D roles, spanning neuroscience, clinical psychology, and engineering. The company also continues to expand its clinical and operational teams to support its scaling efforts.

Company Growth Trajectory Indicators: The healthtech sector in India is experiencing robust growth, with a projected 15-20% increase in hiring activity despite broader funding fluctuations. Marbles Health's ambitious expansion plans in India and its strategic pursuit of international markets signify a strong growth trajectory.

Company Size and Expansion Metrics: The company is planning to expand its presence across 15 locations within India, including major Tier-I and Tier-II cities like Delhi-NCR, Hyderabad, Mumbai, Bengaluru, Kolkata, and Chennai. This indicates a significant increase in operational footprint and corresponding talent requirements.

7. Social Media Presence and Engagement

Digital Footprint

Marbles Health maintains a professional digital footprint primarily through media coverage, company announcements, and thought leadership initiatives.

Brand Messaging and Positioning: The company effectively communicates its vision of making brain strength a core part of healthcare and highlights its innovative approach to treating psychiatric and neurological disorders.

Thought Leadership Initiatives: Founders and key personnel contribute expert insights in the neurotech space, often featured in news articles and industry publications, positioning Marbles Health as a leader in brain health solutions.

Notable Campaigns or Content: While specific social media campaigns are not detailed, news articles and press releases serve as primary channels for brand positioning, showcasing product advancements, clinical trial results, and regulatory approvals.